Administration of erythropoiesis‐stimulating agents in patients undergoing haemodialysis: A time and motion study

SUMMARY Background International guidelines recommend treatment of anaemia due to chronic kidney disease (CKD) with erythropoiesis‐stimulating agents (ESAs). Objective To document the time required and the cost in terms of nursing time to prepare and administer ESAs to patients on facility based hae...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of renal care 2017-12, Vol.43 (4), p.219-225
Hauptverfasser:	Johnson, David W., Cleland, Bruce, Eris, Josette, Rafferty, Tom, Sud, Kamal, Chow, Josephine S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Anaemia Anemia Australia Chronic kidney disease Cost control Cost-Benefit Analysis - statistics & numerical data Drug administration Drug therapy Erythrocytes Erythropoiesis‐stimulating agents Female Haemodialysis Healthcare costs Hematinics - administration & dosage Hematinics - therapeutic use Hemodialysis Humans Male Middle Aged Nursing Nursing care Prospective Studies Renal Dialysis - methods Renal Dialysis - statistics & numerical data Renal Insufficiency, Chronic - economics Renal Insufficiency, Chronic - therapy Time and Motion Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!